Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma
Clinical trial NCT07365280 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07365280
- Sponsor
- ZSky Biotech Inc
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-09
- Primary completion
- 2028-12-24
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.